Allakos Inc (ALLK) Company Profile & Statistics

Allakos Inc
ALLK
(Nasdaq - US)
Closed
1.35
+0.00 (0.00%)
in:usd•As of: Nov 08, 2024 15:59 UTC -5
Open
1.38
High
1.38
Low
1.33

About Allakos Inc

CEO

Robert Alexander

Headquarters

825 industrial road, suite 500

redwood city, ca 94070, united states

Auditor

Ernst & Young LLP

Employees

131

Share Holders

Website

www.allakos.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Allakos Inc. is a clinical stage bio-technology company. It discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory and proliferative diseases. Allakos Inc. is based in CA, United States.

Allakos Inc Statistics

Valuation Measures

Market Capitalization ²	119.95M
Enterprise Value	109.50M
Enterprise Value/EBITDA (ttm)	-0.59
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.49
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-127.19%
Return on Invested Capital (ttm)	-157.87%
Return on Assets (ttm)	-78.60%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-185.59M
Net Income Avi to Common (ttm)	-178.75M
Diluted EPS (ttm)	-2.03

Share Statistics

Beta (5Y Monthly)	1.03
52-Week Change	-28.19%
S&P500 52-Week Change	36.80%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	89.34M
Dividend Yield	0.00%
Float ⁴	74.53M
% Held by Insiders	16.12%
% Held by Institutions	84.64%

Balance Sheet

Total Cash (mrq)	92.72M
Total Cash Per Share (mrq)	1.04
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	3.57%
Quick Ratio (mrq)	3.57%
Book Value Per Share (mrq)	0.95

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.56
Free Cash Flow (ytd)	-49.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Allakos Inc

Trade With A Regulated Broker